02Jul/13

NICE issues second draft guidance on the use of Pixuvri as monotherapy to … – pharmabiz.com

NICE issues second draft guidance on the use of Pixuvri as monotherapy to …
pharmabiz.com
The European Medicines Agency’s (the EMA) Committee for Medicinal Products for Human Use has accepted PIX306, CTI’s ongoing randomized controlled Phase 3 clinical trial, which compares Pixuvri-rituximab to gemcitabine-rituximab in patients who have …